- Contributors
- Symbols and Abbreviations
- Chapter 1 Pathophysiology of osteoporosis
- Chapter 2 Epidemiology of osteoporotic fracture
- Chapter 3 Diagnosis of osteoporosis
- Chapter 4 Osteoporosis risk assessment
- Chapter 5 Fracture liaison services
- Chapter 6 Calcium and vitamin D deficiency and therapy
- Chapter 7 Bisphosphonates
- Chapter 8 Hormone replacement therapy (HRT) and selective oestrogen receptor modulators (SERMs)
- Chapter 9 Strontium ranelate (SR)
- Chapter 10 Parathyroid hormone
- Chapter 11 Denosumab
- Chapter 12 Vertebroplasty and kyphoplasty
- Chapter 13 Physiotherapy approach to osteoporosis
- Chapter 14 Osteoporosis in men
- Chapter 15 Glucocorticoid-induced osteoporosis (GIO)
- Chapter 16 Osteoporosis and SREs in neoplastic disease
- Chapter 17 Osteoporosis, osteodystrophy, and CKD-MBD in renal disease
- Chapter 18 Pre-menopausal osteoporosis
- Chapter 19 Osteoporosis in children and adolescents
- Chapter 20 Assessment and management of falls
- Chapter 21 The surgical management of fragility fractures
- Index
(p. 51) Bisphosphonates
- Chapter:
- (p. 51) Bisphosphonates
- Author(s):
Richard W. Keen
- DOI:
- 10.1093/med/9780198713340.003.0007
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Contributors
- Symbols and Abbreviations
- Chapter 1 Pathophysiology of osteoporosis
- Chapter 2 Epidemiology of osteoporotic fracture
- Chapter 3 Diagnosis of osteoporosis
- Chapter 4 Osteoporosis risk assessment
- Chapter 5 Fracture liaison services
- Chapter 6 Calcium and vitamin D deficiency and therapy
- Chapter 7 Bisphosphonates
- Chapter 8 Hormone replacement therapy (HRT) and selective oestrogen receptor modulators (SERMs)
- Chapter 9 Strontium ranelate (SR)
- Chapter 10 Parathyroid hormone
- Chapter 11 Denosumab
- Chapter 12 Vertebroplasty and kyphoplasty
- Chapter 13 Physiotherapy approach to osteoporosis
- Chapter 14 Osteoporosis in men
- Chapter 15 Glucocorticoid-induced osteoporosis (GIO)
- Chapter 16 Osteoporosis and SREs in neoplastic disease
- Chapter 17 Osteoporosis, osteodystrophy, and CKD-MBD in renal disease
- Chapter 18 Pre-menopausal osteoporosis
- Chapter 19 Osteoporosis in children and adolescents
- Chapter 20 Assessment and management of falls
- Chapter 21 The surgical management of fragility fractures
- Index